• SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV

    Friday September 8th 2023

  • The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain

    Tuesday September 5th 2023

  • SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure

    Friday September 1st 2023

  • Biocartis partners with Lilly to explore biomarker testing for NSCLC patients using the Idylla™ Platform

    Thursday August 10th 2023

  • SwiftPharma and ONO Exponential Farming join forces in an exclusive strategic alliance to develop a circular biomanufacturing platform based on plant molecular farming

    Wednesday August 9th 2023

  • ‘Human inks’ to 3D printing human tissues: HU3DINKS project brings together expert companies for the development of human tissue-based inks

    Monday July 24th 2023

  • Confo Therapeutics enters into research collaboration for GPCR-targeting antibody discovery with AbCellera

    Friday June 16th 2023

  • Biotech in Vlaanderen: een straf verhaal

    Wednesday May 31st 2023

  • Your news here?

  • Biocartis and HiloProbe to collaborate on colorectal cancer test

    Tuesday May 9th 2023

  • Vrije Universiteit Brussel (VUB) and InSphero partner to advance drug discovery for Non-Alcoholic Steatohepatitis

    Thursday May 4th 2023

  • Mithra and the University of Liège secure proof-of-concept for novel manufacturing process of E4

    Thursday May 4th 2023


Strategic Partners